Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-120395
Filing Date
2025-12-11
Accepted
2025-12-11 09:22:26
Documents
4
Period of Report
2025-12-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0269296-6k_newcelx.htm 6-K 9863
2 PRESS RELEASE TITLED: "NEWCELX EXPANDS INTELLECTUAL PROPERTY FOOTPRINT WITH PUBL ea026929601ex99-1_newcelx.htm EX-99.1 16255
3 GRAPHIC ex99-1_001.jpg GRAPHIC 18727
4 GRAPHIC ex99-1_002.jpg GRAPHIC 87772
  Complete submission text file 0001213900-25-120395.txt   174290
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NewcelX Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 251563692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)